Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Berthois

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Endocrinology|March 1, 1994
Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding siteY Berthois, M Pons, C Dussert, et al.
Oncogene|December 22, 1999
Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell lineL Ma, C Gauvillé, Y Berthois, et al.
British Journal of Cancer|January 13, 2006
Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survivalS Desruisseau, J Palmari, C Giusti, et al.
Biochemical and Biophysical Research Communications|September 15, 1994
Relationship between the MAP kinase activity and the dual effect of EGF on A431 cell proliferationN Chajry, P M Martin, G Pages, et al.
International Journal of Medical Informatics|August 1, 1997
A minimal model for calcium signal generated by tyrosine kinase and G protein linked receptors; a stochastic computer simulation with CALSIMP Seghieri, C Dussert, J Palmari, et al.
Anticancer Research|July 24, 2010
Antisense inhibition of amphiregulin expression reduces EGFR phosphorylation in transformed human breast epithelial cellsL Ma, E Huet, M Serova, et al.
Journal of Steroid Biochemistry|December 1, 1986
Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systemsY Berthois, N Pourreau-Schneider, P Gandilhon, et al.
Journal of Steroid Biochemistry|December 1, 1984
Estrogen response of MCF-7 cells grown on diverse substrates and in suspension culture: promotion of morphological heterogeneity, modulation of progestin receptor induction; cell-substrate interactions on collagen gelsN Pourreau-Schneider, Y Berthois, H Mittre, et al.
Anticancer Research|November 1, 1992
Mode of EGF action on cell cycle kinetics in human breast cancer cell line MCF-7: some evidence that EGF acts as a "progression factor"X F Dong, Y Berthois, C Dussert, et al.
British Journal of Cancer|February 6, 2003
SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivoY Berthois, B Bourrié, S Galiègue, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Endocrinology|March 1, 1994
Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding siteY Berthois, M Pons, C Dussert, et al.
Oncogene|December 22, 1999
Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell lineL Ma, C Gauvillé, Y Berthois, et al.
British Journal of Cancer|January 13, 2006
Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survivalS Desruisseau, J Palmari, C Giusti, et al.
Biochemical and Biophysical Research Communications|September 15, 1994
Relationship between the MAP kinase activity and the dual effect of EGF on A431 cell proliferationN Chajry, P M Martin, G Pages, et al.
International Journal of Medical Informatics|August 1, 1997
A minimal model for calcium signal generated by tyrosine kinase and G protein linked receptors; a stochastic computer simulation with CALSIMP Seghieri, C Dussert, J Palmari, et al.
Anticancer Research|July 24, 2010
Antisense inhibition of amphiregulin expression reduces EGFR phosphorylation in transformed human breast epithelial cellsL Ma, E Huet, M Serova, et al.
Journal of Steroid Biochemistry|December 1, 1986
Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systemsY Berthois, N Pourreau-Schneider, P Gandilhon, et al.
Journal of Steroid Biochemistry|December 1, 1984
Estrogen response of MCF-7 cells grown on diverse substrates and in suspension culture: promotion of morphological heterogeneity, modulation of progestin receptor induction; cell-substrate interactions on collagen gelsN Pourreau-Schneider, Y Berthois, H Mittre, et al.
Anticancer Research|November 1, 1992
Mode of EGF action on cell cycle kinetics in human breast cancer cell line MCF-7: some evidence that EGF acts as a "progression factor"X F Dong, Y Berthois, C Dussert, et al.
British Journal of Cancer|February 6, 2003
SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivoY Berthois, B Bourrié, S Galiègue, et al.
Pageof 4